There is still a place for optimised thiopurine therapy in IBD
- PMID: 33239341
- DOI: 10.1136/gutjnl-2020-323481
There is still a place for optimised thiopurine therapy in IBD
Keywords: 6-mercaptopurine; Crohn's disease; azathioprine; inflammatory bowel disease; ulcerative colitis.
Conflict of interest statement
Competing interests: NKHdB has served as a speaker for AbbVie and MSD and has served as consultant and principal investigator for TEVA Pharma BV and Takeda. He has received a (unrestricted) research grant from Dr Falk, TEVA Pharma BV, MLDS and Takeda.
Comment on
-
Thiopurine monotherapy has a limited place in treatment of patients with mild-to-moderate Crohn's disease.Gut. 2021 Jul;70(7):1416-1418. doi: 10.1136/gutjnl-2020-322646. Epub 2020 Sep 14. Gut. 2021. PMID: 32928916 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical